{"AllianceGenome": "6211", "HGNC": "6211", "MIM": "300836", "_id": "3730", "_version": 1, "accession": {"genomic": ["AC005184.1", "AC006062.5", "AC096511.4", "CH471074.1", "CP068255.2", "NC_000023.11", "NC_060947.1", "NG_007088.2", "X68770.1", "X82034.1"], "protein": ["AAA59202.1", "AAB20108.1", "AAI37427.1", "AAI37428.1", "AKS36874.1", "CAA42841.1", "CAA57554.1", "EAW98759.1", "NP_000207.2", "P23352.3", "XP_005274558.1", "XP_054183011.1"], "rna": ["AA678961.1", "AH003768.2", "AI582702.1", "BC137426.1", "BC137427.1", "CD642906.1", "CN417843.1", "DA809233.1", "DB214183.1", "KP769542.1", "M97252.1", "NM_000216.4", "X60299.1", "XM_005274501.5", "XM_054327036.1"], "translation": [{"protein": "CAA42841.1", "rna": "X60299.1"}, {"protein": "AAI37427.1", "rna": "BC137426.1"}, {"protein": "AKS36874.1", "rna": "KP769542.1"}, {"protein": "AAA59202.1", "rna": "M97252.1"}, {"protein": "XP_005274558.1", "rna": "XM_005274501.5"}, {"protein": "AAI37428.1", "rna": "BC137427.1"}, {"protein": "NP_000207.2", "rna": "NM_000216.4"}, {"protein": "XP_054183011.1", "rna": "XM_054327036.1"}, {"protein": "AAB20108.1", "rna": "AH003768.2"}]}, "alias": ["ADMLX", "HH1", "HHA", "KAL", "KAL1", "KALIG-1", "KMS", "WFDC19"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2022-05-17T22:31:52.758Z", "disease_label": "hypogonadotropic hypogonadism 1 with or without anosmia", "gcep": "Syndromic Disorders Gene Curation Expert Panel", "moi": "XL", "mondo": "MONDO:0010635", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2b7650b6-f2b6-4ac3-a967-3e631c98d7b1-2022-05-17T223152.758Z", "sop": "SOP8"}}, "ec": "3.4.21.4", "ensembl": {"gene": "ENSG00000011201", "protein": "ENSP00000262648", "transcript": ["ENST00000262648", "ENST00000481896", "ENST00000488294"], "translation": [{"protein": "ENSP00000262648", "rna": "ENST00000262648"}], "type_of_gene": "protein_coding"}, "entrezgene": "3730", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 21.7905274274, "exp_mis": 143.003568454, "exp_syn": 69.5903107165, "lof_z": 3.98744567866299, "mis_z": 0.818184223167406, "mu_lof": 2.5537778701e-06, "mu_mis": 2.21997262667e-05, "mu_syn": 1.06648003078e-05, "n_lof": 3.0, "n_mis": 123.0, "n_syn": 68.0, "p_li": 0.938574322654335, "p_null": 2.17671965758086e-06, "p_rec": 0.0614235006260076, "syn_z": 0.118183503668448}, "bp": 2043, "cds_end": 8700077, "cds_start": 8501035, "n_exons": 14, "nonpsych": {"exp_lof": 19.5837927834, "exp_mis": 129.529096825, "exp_syn": 62.9401991011, "lof_z": 3.68033613805454, "mis_z": 0.688215322643504, "mu_lof": 2.5537778701e-06, "mu_mis": 2.21997262667e-05, "mu_syn": 1.06648003078e-05, "n_lof": 3.0, "n_mis": 114.0, "n_syn": 60.0, "p_li": 0.884609541688993, "p_null": 1.34213291246494e-05, "p_rec": 0.115377036981882, "syn_z": 0.233333044602304}, "nontcga": {"exp_lof": 19.785467315, "exp_mis": 130.184741646, "exp_syn": 63.3208945301, "lof_z": 3.72255892651682, "mis_z": 0.794030043979484, "mu_lof": 2.5537778701e-06, "mu_mis": 2.21997262667e-05, "mu_syn": 1.06648003078e-05, "n_lof": 3.0, "n_mis": 112.0, "n_syn": 61.0, "p_li": 0.882605262666924, "p_null": 1.149210762783e-05, "p_rec": 0.117383245225448, "syn_z": 0.184672973525188}, "transcript": "ENST00000262648.3"}, "exons": [{"cdsend": 8732036, "cdsstart": 8532994, "chr": "X", "position": [[8528873, 8533053], [8534318, 8534460], [8535590, 8535811], [8536770, 8536942], [8539663, 8539758], [8553951, 8554098], [8568231, 8568376], [8570498, 8570704], [8585266, 8585396], [8587793, 8587978], [8597033, 8597256], [8623607, 8623670], [8699697, 8699745], [8731829, 8732137]], "strand": -1, "transcript": "NM_000216", "txend": 8732137, "txstart": 8528873}], "exons_hg19": [{"cdsend": 8700077, "cdsstart": 8501035, "chr": "X", "position": [[8496914, 8501094], [8502359, 8502501], [8503631, 8503852], [8504811, 8504983], [8507704, 8507799], [8521992, 8522139], [8536272, 8536417], [8538539, 8538745], [8553307, 8553437], [8555834, 8556019], [8565074, 8565297], [8591648, 8591711], [8667738, 8667786], [8699870, 8700178]], "strand": -1, "transcript": "NM_000216", "txend": 8700178, "txstart": 8496914}], "generif": [{"pubmed": 12050219, "text": "Identification of three novel mutations in the KAL1 gene in patients with Kallmann syndrome."}, {"pubmed": 12627230, "text": "AL1 gene product, the extracellular matrix protein anosmin-1, is involved in FGF signaling"}, {"pubmed": 15001591, "text": "six novel and two recurrent intragenic KAL1 mutations in seven familial and four sporadic male cases of Kallmann syndrome"}, {"pubmed": 15004876, "text": "it is unlikely that KAL gene mutations are a clinically significant cause of sporadic GnRH deficiency in female patients"}, {"pubmed": 15324302, "text": "anosmin-1 may modulate the catalytic activity of uPA and its signalling pathway, whereas HS determines cell surface localization of the anosmin-1-uPA complex"}, {"pubmed": 15471890, "text": "a direct action of anosmin-1 on the migratory activity of GnRH neurons is shown"}, {"pubmed": 15548653, "text": "anosmin-1 is an isoform-specific co-ligand modulator of FGFR signaling that amplifies and specifies FGFR1 signaling responses during human nervous system development and defines the link between autosomal and X-linked Kallmann's syndrome"}, {"pubmed": 15636431, "text": "KAL1 gene has a closely related nonfunctional pseudogene on the Y chromosome"}, {"pubmed": 15949815, "text": "analysis of the biological function of anosmin-1 and its ability to interact with its three macromolecular ligands"}, {"pubmed": 16876430, "text": "Data suggest that the relative concentrations of Anosmin-1 and FGF-2 modulate the migration of oligodendrocyte precursors during development through their interaction with FGFR1."}, {"pubmed": 17213338, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 17603054, "text": "The phenotype of renal agenesis/dysgenesis strongly indicates the existence of KAL1 gene defects in the genotype of patients with sporadic Kallmann syndrome."}, {"pubmed": 18160472, "text": "KAL1 mutations result in a more severe reproductive phenotype than FGFR1/KAL2 mutations."}, {"pubmed": 18463157, "text": "12% of Kallman syndrome males have KAL1 deletions, but intragenic deletions of the FGFR1, GNRH1, GNRHR, GPR54 and NELF genes are uncommon in Idiopathic hypogonadotropic hypogonadism/Kallman syndrome."}, {"pubmed": 18682503, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18723471, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19696444, "text": "binding of anosmin-1 to FGFR1 and heparin can play a dual role in assembly and activity of the ternary FGFR1.FGF2.heparin complex."}, {"pubmed": 19734936, "text": "report describes 2 intragenic deletions of KAL-1 in 2 Kallmann syndrome (KS) patients & suggests KAL-1 deletion may be more prevalent in KS patients with other congenital organ abnormalities than those described previously from Northwestern China"}, {"pubmed": 19844165, "text": "KAL1 gene expression plays an important role in cancer metastasis and protection from apoptosis."}, {"pubmed": 20219326, "text": "Anosmin-1 produced by epidermal keratinocytes in response to calcium concentrations or cytokines may modulate epidermal nerve density in atopic dermatitis."}, {"pubmed": 20362962, "text": "Mutations of KAL1 underlie an autosomal dominant form of Kallmann syndrome."}, {"pubmed": 20530987, "text": "Role of the KAL1 protein missense mutations in Kallman syndrome and in olfactory bulb development."}, {"pubmed": 20734064, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21351529, "text": "Two new mutations were detected in KAL1 from male patients with idiopathic hypogonadotropic hypogonadism."}, {"pubmed": 21497178, "text": "A central role of KAL-1, in GnRH neuron ontogeny - specifically in GnRH neuronal migration from the cribriform plate area into the brain."}, {"pubmed": 21682876, "text": "Comprehensive mutation analysis of all 7 known KS genes (KAL1, FGFR1, FGF8, PROK2, PROKR2, CHD7, and WDR11) in 30 well-phenotyped probands revealed mutations in KAL1 (3 men) and FGFR1 (all 5 women vs. 4/25 men), but not in other genes in Finland patients."}, {"pubmed": 21717404, "text": "we report the case of a deletion of exons 4 to 14 (c.469-?_6314+?del) within the KAL1 gene in two related patients and in three female carriers among the members of the presented family."}, {"pubmed": 22016523, "text": "The results of this study proposed that FGF-2 and Anosmin-1 are markers for the histopathological type and the level of inflammation of multiple sclerosis lesions"}, {"pubmed": 22801565, "text": "Peculiar prolactinomas in patients with pituitary developmental Kal 2 gene mutations"}, {"pubmed": 23189990, "text": "we demonstrate that missense mutations reported in patients with KS, C172R and N267K did not alter or substantially reduce, respectively, the binding to FGFR1"}, {"pubmed": 23357298, "text": "Increased presence of anosmin-1 in TGF-beta treated human retinal pigment epithelial cells cells, with distinct localization at the intercellular junctions."}, {"pubmed": 23410897, "text": "Mutation analysis reveals a missense mutation of KAL1 in two brothers with Kallmann syndrome, while their mother is heterozygous for this missense mutation encoded by the single-nucleotide polymorphism rs2229013."}, {"pubmed": 23533228, "text": "genetic association studies in population in Massachusetts: Data suggest that clinical features in Kallmann syndrome (KS) are highly associated with genetic causes: synkinesia is associated with genetic variations/mutations in KAL1."}, {"pubmed": 23721716, "text": "These results indicate that intragenic multiexon deletions are one of the most frequent KAL1 abnormalities, which can be more accurately detected by multiplex ligation-dependent probe amplification."}, {"pubmed": 24002956, "text": "No abnormalities were found in the patient group for the PROKR2 and GNRH1genes. In addition, no genomic rearrangements were identified in the healthy control individuals for the described genes"}, {"pubmed": 24189182, "text": "Anosmin-1 can facilitate tumor cell proliferation, migration, invasin, and survival."}, {"pubmed": 24232061, "text": "Two brothers presented with a sensorineural hearing impairment associated with cryptorchidism and abnormal movements. Genome-wide array analysis identified a large deletion of KAL1 in both patients confirming the diagnosis of Kallmann syndrome."}, {"pubmed": 24732674, "text": "Mutations were found in the following genes in one or more patients with congenital hypogonadotropic hypogonadism: KAL1, FGFR1, GNRHR, and CHD7"}, {"pubmed": 25060050, "text": "data indicated KAL1 plays potential suppressive role on OSCC initiation and progression. KAL1 gene may serve as adjuvant biomarker for identification of pathological grade."}, {"pubmed": 25300141, "text": "anosmin-1 has been identified in other pathological scenarios both within (multiple sclerosis) and outside (cancer, atopic dermatitis) the central nerve system."}, {"pubmed": 25300351, "text": "FGF receptor 1-mediated anosmin-1 activity plays a crucial role in the continuous remodelling of the adult olfactory bulb."}, {"pubmed": 25662897, "text": "Anosmin-1 over-expression regulates oligodendrocyte precursor cell proliferation, migration and myelin sheath thickness. Data confirmed the involvement of (A1) works as a chemotropic cue contributing to axonal outgrowth and in oligodendrogliogenesis and its relevance for myelination."}, {"pubmed": 25726327, "text": "Our analyses show that the two phenotypes in our patient are due to independent genetic defects: a genomic rearrangement involving the KAL1 gene and a point mutation of the steryl-sulfatase gene."}, {"pubmed": 25892360, "text": "Results indicated that KAL1 may act as a putative tumor suppressor in hepatocellular carcinoma (HCC) and is inactivated by promoter hypermethylation. KAL1 may serve as a biomarker of malignant phenotype of HCC."}, {"pubmed": 26051373, "text": "Kallmann syndrome with FGFR1 and KAL1 mutations was detected during fetal life"}, {"pubmed": 26278626, "text": "two novel variants, KAL1 (c.146G>T (p.Cys49Phe)) and mitochondrial tRNAcys (m.5800A>G), were identified in a large Han Chinese family with inherited Kallmann syndrome; although two variants can't exert obvious effects on the migration of GnRH neurons, they show a synergistic effect, which can account for the occurrence of the disorder in this family"}, {"pubmed": 26375424, "text": "Study reports 2 new mutations in KAL1 gene from patients with septo-optic dysplasia proven to be loss-of-function."}, {"pubmed": 27184500, "text": "This study presents the first experimental evidence indicating a molecular interaction between anosmin 1 and PKR2. A truncated anosmin 1 protein comprising the first three domains of the protein interacts with the second extracellular loop of PKR2, involved in PK2 binding."}, {"pubmed": 28122887, "text": "Hemizygous mutations were identified in three Kallman syndrome cases: a novel splice acceptor site mutation leading to skipping of exon 5 in the ANOS1 transcript in a patient with self-reported normosmia (but hyposmic upon testing); a recurrent nonsense mutation and a novel 4.8 Mb deletion involving ANOS1 and eight other genes (VCX3B, VCX2, PNPLA4, VCX, STS, HDHD1, VCX3A and NLGN4X) in KS associated with ichthyosis."}, {"pubmed": 28780519, "text": "The prevalence of ANOS1 gene mutations is higher in familial Chinese Kallmann Syndrome patients."}, {"pubmed": 28854193, "text": "ANOS1 expression shows continuous activation during the progression of colorectal cancer, its expression is closely related to the overall survival rate of patients."}, {"pubmed": 29211946, "text": "A pathogenic variant was identified in the ANOS1 gene on the X chromosome: c.1267C>T, in 2 brothers who were hemizygous, and their mother, who was heterozygous for the variant."}, {"pubmed": 29222041, "text": "Tumor protein p73 (TAp73) and kallmann syndrome 1 sequence protein (KAI1) expression levels are positively correlated in colorectal cancer."}, {"pubmed": 31377880, "text": "Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study."}, {"pubmed": 31669640, "text": "The deleterious effect of this mutation on the transcriptional level of ANOS1 gene."}, {"pubmed": 34062169, "text": "Genetics of hypogonadotropic Hypogonadism-Human and mouse genes, inheritance, oligogenicity, and genetic counseling."}, {"pubmed": 36039580, "text": "ANOS1 variants in a large cohort of Chinese patients with congenital hypogonadotropic hypogonadism.\", trans \"ANOS1."}, {"pubmed": 36859276, "text": "Mutation spectrum of Kallmann syndrome: identification of five novel mutations across ANOS1 and FGFR1."}], "genomic_pos": {"chr": "X", "end": 8732137, "ensemblgene": "ENSG00000011201", "start": 8528874, "strand": -1}, "genomic_pos_hg19": {"chr": "X", "end": 8700227, "start": 8496915, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0006935", "qualifier": "involved_in", "term": "chemotaxis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007155", "qualifier": "involved_in", "term": "cell adhesion"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007411", "pubmed": 1922361, "qualifier": "involved_in", "term": "axon guidance"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0030182", "qualifier": "involved_in", "term": "neuron differentiation"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005615", "pubmed": 8842728, "qualifier": "located_in", "term": "extracellular space"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0009986", "qualifier": "is_active_in", "term": "cell surface"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0031012", "pubmed": 8832397, "qualifier": "located_in", "term": "extracellular matrix"}], "MF": [{"category": "MF", "evidence": "IEA", "id": "GO:0004867", "qualifier": "enables", "term": "serine-type endopeptidase inhibitor activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0005201", "pubmed": 8842728, "qualifier": "enables", "term": "extracellular matrix structural constituent"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [19696444, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0008201", "qualifier": "enables", "term": "heparin binding"}]}, "homologene": {"genes": [[6239, 173282], [7955, 30630], [8364, 100135017], [9031, 396395], [9544, 708336], [9598, 465480], [9606, 3730], [9615, 610921], [9913, 525898]], "id": 55445}, "interpro": [{"desc": "Fibronectin type III", "id": "IPR003961", "short_desc": "FN3_dom"}, {"desc": "WAP-type 'four-disulfide core' domain", "id": "IPR008197", "short_desc": "WAP_dom"}, {"desc": "Immunoglobulin-like fold", "id": "IPR013783", "short_desc": "Ig-like_fold"}, {"desc": "Fibronectin type III superfamily", "id": "IPR036116", "short_desc": "FN3_sf"}, {"desc": "Elafin-like superfamily", "id": "IPR036645", "short_desc": "Elafin-like_sf"}, {"desc": "Anosmin-1, cysteine rich domain", "id": "IPR040957", "short_desc": "Anosmin-1_Cys_box"}, {"desc": "Anosmin-1", "id": "IPR042447", "short_desc": "Anosmin-1"}], "ipi": "IPI00011174", "map_location": "Xp22.31", "name": "anosmin 1", "other_names": ["Kallmann syndrome interval gene 1", "Kallmann syndrome-1 sequence (anosmin-1)", "WAP four-disulfide core domain 19", "adhesion molecule-like X-linked", "anosmin-1", "kallmann syndrome protein"], "pantherdb": {"HGNC": "6211", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"Ensembl": "ENSGALG00000035266", "ortholog_type": "O", "panther_family": "PTHR14131", "taxid": 9031, "uniprot_kb": "A0A452J818"}, {"Gene": "ANOS1", "ortholog_type": "LDO", "panther_family": "PTHR14131", "taxid": 9031, "uniprot_kb": "P33005"}, {"ZFIN": "ZDB-GENE-000201-13", "ortholog_type": "O", "panther_family": "PTHR14131", "taxid": 7955, "uniprot_kb": "Q1MT36"}, {"ZFIN": "ZDB-GENE-000201-9", "ortholog_type": "LDO", "panther_family": "PTHR14131", "taxid": 7955, "uniprot_kb": "F1R469"}, {"WormBase": "WBGene00002181", "ortholog_type": "LDO", "panther_family": "PTHR14131", "taxid": 6239, "uniprot_kb": "G5EDX1"}, {"FlyBase": "FBgn0039155", "ortholog_type": "LDO", "panther_family": "PTHR14131", "taxid": 7227, "uniprot_kb": "Q9VCC7"}], "uniprot_kb": "P23352"}, "pathway": {"reactome": [{"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-190236", "name": "Signaling by FGFR"}, {"id": "R-HSA-190242", "name": "FGFR1 ligand binding and activation"}, {"id": "R-HSA-190373", "name": "FGFR1c ligand binding and activation"}, {"id": "R-HSA-5654726", "name": "Negative regulation of FGFR1 signaling"}, {"id": "R-HSA-5654736", "name": "Signaling by FGFR1"}, {"id": "R-HSA-9006934", "name": "Signaling by Receptor Tyrosine Kinases"}], "wikipathways": [{"id": "WP5053", "name": "Development of ureteric collection system"}, {"id": "WP5074", "name": "Kallmann,s Syndrome"}]}, "pdb": "1ZLG", "pfam": ["PF00041", "PF00095", "PF17869"], "pharmgkb": "PA30012", "pharos": {"target_id": 8853, "tdl": "Tbio"}, "pir": ["A40351", "S17982"], "prosite": ["PS50853", "PS51390"], "reagent": {"CondMedia_CM_LibrAB": [{"id": "GNF293208", "relationship": "is"}, {"id": "GNF293284", "relationship": "is"}], "GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF167919", "relationship": "is"}, {"id": "GNF178825", "relationship": "is"}, {"id": "GNF189731", "relationship": "is"}, {"id": "GNF200637", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF042538", "relationship": "is"}, "NIBRI_hs-Secretome_pDEST": {"id": "GNF339008", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF105064", "relationship": "is"}, {"id": "GNF115600", "relationship": "similar to"}, {"id": "GNF144711", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000023.11", "NC_060947.1", "NG_007088.2"], "protein": ["NP_000207.2", "XP_005274558.1", "XP_054183011.1"], "rna": ["NM_000216.4", "XM_005274501.5", "XM_054327036.1"], "translation": [{"protein": "XP_054183011.1", "rna": "XM_054327036.1"}, {"protein": "XP_005274558.1", "rna": "XM_005274501.5"}, {"protein": "NP_000207.2", "rna": "NM_000216.4"}]}, "reporter": {"GNF1H": "gnf1h07134_s_at", "HG-U133_Plus_2": ["205206_at", "229853_at"], "HG-U95Av2": "33158_at", "HTA-2_0": "TC0X000829.hg.1", "HuEx-1_0": ["3998766", "4030268"], "HuGene-1_1": "8171248", "HuGene-2_1": ["17108959", "17125718", "17125722"]}, "retired": 139620, "summary": "Mutations in this gene cause the X-linked Kallmann syndrome. The encoded protein is similar in sequence to proteins known to function in neural cell adhesion and axonal migration. In addition, this cell surface protein is N-glycosylated and may have anti-protease activity. [provided by RefSeq, Jul 2008].", "symbol": "ANOS1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1416536"}, "unigene": "Hs.521869", "uniprot": {"Swiss-Prot": "P23352"}}